Sign In
Buy ALLR
$1.19
-0.0300 (-2.46%)
At Close: Jul 24, 2026
NEW YORK, NY / ACCESSWIRE / July 26, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Allarity Therapeutics, Inc. ("Allarity" or "the Company") (N
Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting
09:00am, Friday, 26'th Jul 2024
Boston (July 26, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer t
Allarity Therapeutics, Inc. (ALLR) Shareholders May Have Been Affected by Fraud - Levi & Korsinsky Investigates
07:50pm, Thursday, 25'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 25, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Allarity Therapeutics, Inc. ("Allarity") (NASDAQ:ALLR) concerning possible vio
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Allarity Therapeutics, Inc. - ALLR
07:36pm, Thursday, 25'th Jul 2024
NEW YORK , July 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ: ALLR). Such investors are
ALLR Investors Have The Opportunity To Join The Allarity Therapeutics, Inc. Securities Fraud Investigation With The Schall Law Firm
03:30pm, Thursday, 25'th Jul 2024
LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Allarity Therapeu
Lost Money on Allarity Therapeutics, Inc.(ALLR)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
03:45pm, Wednesday, 24'th Jul 2024
NEW YORK, NY / ACCESSWIRE / July 24, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Allarity Therapeutics, Inc. ("Allarity") (NASDAQ:ALLR) concerning possible vio
ALLR Stock Alert: Allarity Therapeutics Pushes Shareholders to Back Reverse Split
12:30pm, Wednesday, 24'th Jul 2024
Allarity Therapeutics (NASDAQ: ALLR ) stock is on the rise Wednesday as the clinical-stage biopharmaceutical company is encouraging its shareholders to vote in favor of a reverse stock split. Allarity
Reinhausen Manufacturing Inc Celebrates Ribbon Cutting for Plant Expansion in Humboldt
06:22pm, Tuesday, 23'rd Jul 2024
HUMBOLDT, Tenn.--(BUSINESS WIRE)--Reinhausen Manufacturing Inc. (RM), a subsidiary of Germany-based Maschinenfabrik Reinhausen, is thrilled to announce the official ribbon cutting of its newly expande
Allarity Therapeutics Outlines Company's 2024 Progress and Objectives
06:30am, Monday, 22'nd Jul 2024
Current Cash Balance of $20 million Expected to Provide Runway Into 2026 Allarity to Pause Use of ATM Cap Table Successfully Cleaned Up Allarity's Stenoparib Shows Extended Duration of Phase 2 Clinica
Allarity Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
08:00am, Monday, 20'th May 2024
Boston (May 20, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing personalized cancer tr
- Phase 2 Trial of Stenoparib Concluded Early due to Clear Clinical Benefits Achieved - On Track to Regain Compliance with All Nasdaq Listing Requirements - No Variable Priced Securities are Outstandi
All You Need to Know About Allarity Therapeutics, Inc. (ALLR) Rating Upgrade to Buy
01:01pm, Tuesday, 07'th May 2024
Allarity Therapeutics, Inc. (ALLR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock
09:30am, Tuesday, 07'th May 2024
- Conversions Eliminate All Variable Priced Derivative Securities - Conversions Eliminate Any Market Overhang from Warrants - Series A Preferred and Warrant Conversions were Investor Initiated - Limit
Allarity Therapeutics Exceeds Nasdaq's Minimum Equity Requirement; Requests Voluntarily Withdrawal of Form S-1
08:00am, Monday, 06'th May 2024
- Stockholders' equity significantly surpasses the $2.5 million minimum required by Nasdaq
Why Is Allarity Therapeutics (ALLR) Stock Up 39% Today?
10:46am, Thursday, 02'nd May 2024
Allarity Therapeutics (NASDAQ: ALLR ) stock is rocketing higher on Thursday after the clinical-stage biopharmaceutical company shared results from a Phase 2 clinical trial. Allarity Therapeutics annou
